Serveur d'exploration sur le lymphœdème

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Lack of lymphatic vessel phenotype in LYVE‐1/CD44 double knockout mice

Identifieur interne : 006627 ( Main/Exploration ); précédent : 006626; suivant : 006628

Lack of lymphatic vessel phenotype in LYVE‐1/CD44 double knockout mice

Auteurs : Mai X. Luong [États-Unis] ; Joshua Tam [États-Unis] ; Qingcong Lin [États-Unis] ; Jeroen Hagendoorn [États-Unis, Pays-Bas] ; Kathryn J. Moore [États-Unis] ; Timothy P. Padera [États-Unis] ; Brian Seed [États-Unis] ; Dai Fukumura [États-Unis] ; Raju Kucherlapati [États-Unis] ; Rakesh K. Jain [États-Unis]

Source :

RBID : ISTEX:43406FCD0C22975E24F4CEC8596CA244EA8D546F

Abstract

Lymphatic vessels play a key role in maintaining tissue‐fluid homeostasis, immune surveillance and metastasis. The hyaluronan receptor, LYVE‐1, is widely used as a molecular marker for adult and embryonic lymphatic endothelium, but its physiological functions have not yet been established in vivo. In agreement with a recent report, LYVE‐1−/− mice, which are healthy and fertile, do not display any defects related to congenital abnormalities of the lymphatic system. One hypothesis for the absence of a phenotype in LYVE‐1 null mice is that other hyaluronan receptors, such as CD44, may compensate for LYVE‐1. To test this hypothesis, we created LYVE‐1/CD44 double knockout mice with appropriate littermate controls. Lymphatic vessel structure and function, as determined by histological methods and intravital microscopy, show that LYVE‐1−/−, CD44−/− and LYVE‐1−/−/CD44−/− mice are indistinguishable from wild‐type mice under normal conditions. Furthermore, resolution of carrageenan‐induced paw edema is comparable in all genotypes. However, LYVE‐1−/−/CD44−/− mice exhibit increased edema formation in a carrageenan‐induced paw inflammation model compared to wild‐type mice, but not to LYVE−/− or CD44−/− mice. These data suggest that LYVE‐1 and CD44 are not required for the formation or function of lymphatics, but do not rule out a role for LYVE‐1 in inflammation. J. Cell. Physiol. 219: 430–437, 2009. © 2009 Wiley‐Liss, Inc.

Url:
DOI: 10.1002/jcp.21686


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Lack of lymphatic vessel phenotype in LYVE‐1/CD44 double knockout mice</title>
<author>
<name sortKey="Luong, Mai X" sort="Luong, Mai X" uniqKey="Luong M" first="Mai X." last="Luong">Mai X. Luong</name>
</author>
<author>
<name sortKey="Tam, Joshua" sort="Tam, Joshua" uniqKey="Tam J" first="Joshua" last="Tam">Joshua Tam</name>
</author>
<author>
<name sortKey="Lin, Qingcong" sort="Lin, Qingcong" uniqKey="Lin Q" first="Qingcong" last="Lin">Qingcong Lin</name>
</author>
<author>
<name sortKey="Hagendoorn, Jeroen" sort="Hagendoorn, Jeroen" uniqKey="Hagendoorn J" first="Jeroen" last="Hagendoorn">Jeroen Hagendoorn</name>
</author>
<author>
<name sortKey="Moore, Kathryn J" sort="Moore, Kathryn J" uniqKey="Moore K" first="Kathryn J." last="Moore">Kathryn J. Moore</name>
</author>
<author>
<name sortKey="Padera, Timothy P" sort="Padera, Timothy P" uniqKey="Padera T" first="Timothy P." last="Padera">Timothy P. Padera</name>
</author>
<author>
<name sortKey="Seed, Brian" sort="Seed, Brian" uniqKey="Seed B" first="Brian" last="Seed">Brian Seed</name>
</author>
<author>
<name sortKey="Fukumura, Dai" sort="Fukumura, Dai" uniqKey="Fukumura D" first="Dai" last="Fukumura">Dai Fukumura</name>
</author>
<author>
<name sortKey="Kucherlapati, Raju" sort="Kucherlapati, Raju" uniqKey="Kucherlapati R" first="Raju" last="Kucherlapati">Raju Kucherlapati</name>
</author>
<author>
<name sortKey="Jain, Rakesh K" sort="Jain, Rakesh K" uniqKey="Jain R" first="Rakesh K." last="Jain">Rakesh K. Jain</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:43406FCD0C22975E24F4CEC8596CA244EA8D546F</idno>
<date when="2009" year="2009">2009</date>
<idno type="doi">10.1002/jcp.21686</idno>
<idno type="url">https://api.istex.fr/document/43406FCD0C22975E24F4CEC8596CA244EA8D546F/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">001E86</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">001E86</idno>
<idno type="wicri:Area/Istex/Curation">001E86</idno>
<idno type="wicri:Area/Istex/Checkpoint">000D67</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">000D67</idno>
<idno type="wicri:doubleKey">0021-9541:2009:Luong M:lack:of:lymphatic</idno>
<idno type="wicri:source">PMC</idno>
<idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2665001</idno>
<idno type="RBID">PMC:2665001</idno>
<idno type="wicri:Area/Pmc/Corpus">002737</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">002737</idno>
<idno type="wicri:Area/Pmc/Curation">002736</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Curation">002736</idno>
<idno type="wicri:Area/Pmc/Checkpoint">003692</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Checkpoint">003692</idno>
<idno type="wicri:Area/Ncbi/Merge">003180</idno>
<idno type="wicri:Area/Ncbi/Curation">003180</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">003180</idno>
<idno type="wicri:doubleKey">0021-9541:2009:Luong M:lack:of:lymphatic</idno>
<idno type="wicri:Area/Main/Merge">006705</idno>
<idno type="wicri:Area/Main/Curation">006627</idno>
<idno type="wicri:Area/Main/Exploration">006627</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a" type="main" xml:lang="en">Lack of lymphatic vessel phenotype in LYVE‐1/CD44 double knockout mice
<ref type="note" target="#fn1"></ref>
</title>
<author>
<name sortKey="Luong, Mai X" sort="Luong, Mai X" uniqKey="Luong M" first="Mai X." last="Luong">Mai X. Luong</name>
<affiliation wicri:level="2">
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Massachusetts</region>
</placeName>
<wicri:cityArea>Department of Radiation Oncology, Massachusetts General Hospital, Charlestown</wicri:cityArea>
</affiliation>
<affiliation></affiliation>
</author>
<author>
<name sortKey="Tam, Joshua" sort="Tam, Joshua" uniqKey="Tam J" first="Joshua" last="Tam">Joshua Tam</name>
<affiliation wicri:level="2">
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Massachusetts</region>
</placeName>
<wicri:cityArea>Department of Radiation Oncology, Massachusetts General Hospital, Charlestown</wicri:cityArea>
</affiliation>
<affiliation wicri:level="2">
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Massachusetts</region>
</placeName>
<wicri:cityArea>Harvard‐MIT Division of Health Sciences and Technology, Massachusetts Institute of Technology, Cambridge</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Lin, Qingcong" sort="Lin, Qingcong" uniqKey="Lin Q" first="Qingcong" last="Lin">Qingcong Lin</name>
<affiliation wicri:level="2">
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Massachusetts</region>
</placeName>
<wicri:cityArea>Molecular Genetics, Biological Technologies, Wyeth Research, Cambridge</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Hagendoorn, Jeroen" sort="Hagendoorn, Jeroen" uniqKey="Hagendoorn J" first="Jeroen" last="Hagendoorn">Jeroen Hagendoorn</name>
<affiliation wicri:level="2">
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Massachusetts</region>
</placeName>
<wicri:cityArea>Department of Radiation Oncology, Massachusetts General Hospital, Charlestown</wicri:cityArea>
</affiliation>
<affiliation wicri:level="3">
<country xml:lang="fr">Pays-Bas</country>
<wicri:regionArea>Current Address: Department of Surgery, University Medical Center, Utrecht</wicri:regionArea>
<placeName>
<settlement type="city">Utrecht</settlement>
<region nuts="2" type="province">Utrecht (province)</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Moore, Kathryn J" sort="Moore, Kathryn J" uniqKey="Moore K" first="Kathryn J." last="Moore">Kathryn J. Moore</name>
<affiliation wicri:level="2">
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Massachusetts</region>
</placeName>
<wicri:cityArea>Department of Lipid Metabolism, Massachusetts General Hospital, Boston</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Padera, Timothy P" sort="Padera, Timothy P" uniqKey="Padera T" first="Timothy P." last="Padera">Timothy P. Padera</name>
<affiliation wicri:level="2">
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Massachusetts</region>
</placeName>
<wicri:cityArea>Department of Radiation Oncology, Massachusetts General Hospital, Charlestown</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Seed, Brian" sort="Seed, Brian" uniqKey="Seed B" first="Brian" last="Seed">Brian Seed</name>
<affiliation wicri:level="2">
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Massachusetts</region>
</placeName>
<wicri:cityArea>Department of Genetics, Massachusetts General Hospital and Harvard Medical School, Boston</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Fukumura, Dai" sort="Fukumura, Dai" uniqKey="Fukumura D" first="Dai" last="Fukumura">Dai Fukumura</name>
<affiliation wicri:level="2">
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Massachusetts</region>
</placeName>
<wicri:cityArea>Department of Radiation Oncology, Massachusetts General Hospital, Charlestown</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Kucherlapati, Raju" sort="Kucherlapati, Raju" uniqKey="Kucherlapati R" first="Raju" last="Kucherlapati">Raju Kucherlapati</name>
<affiliation wicri:level="2">
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Massachusetts</region>
</placeName>
<wicri:cityArea>Harvard Medical School‐Partners Healthcare Center for Genetics and Genomics, Harvard Medical School, Boston</wicri:cityArea>
</affiliation>
<affiliation></affiliation>
</author>
<author>
<name sortKey="Jain, Rakesh K" sort="Jain, Rakesh K" uniqKey="Jain R" first="Rakesh K." last="Jain">Rakesh K. Jain</name>
<affiliation wicri:level="2">
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Massachusetts</region>
</placeName>
<wicri:cityArea>Department of Radiation Oncology, Massachusetts General Hospital, Charlestown</wicri:cityArea>
</affiliation>
<affiliation></affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j" type="main">Journal of Cellular Physiology</title>
<title level="j" type="alt">JOURNAL OF CELLULAR PHYSIOLOGY</title>
<idno type="ISSN">0021-9541</idno>
<idno type="eISSN">1097-4652</idno>
<imprint>
<biblScope unit="vol">219</biblScope>
<biblScope unit="issue">2</biblScope>
<biblScope unit="page" from="430">430</biblScope>
<biblScope unit="page" to="437">437</biblScope>
<biblScope unit="page-count">8</biblScope>
<publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>Hoboken</pubPlace>
<date type="published" when="2009-05">2009-05</date>
</imprint>
<idno type="ISSN">0021-9541</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">0021-9541</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass></textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Lymphatic vessels play a key role in maintaining tissue‐fluid homeostasis, immune surveillance and metastasis. The hyaluronan receptor, LYVE‐1, is widely used as a molecular marker for adult and embryonic lymphatic endothelium, but its physiological functions have not yet been established in vivo. In agreement with a recent report, LYVE‐1−/− mice, which are healthy and fertile, do not display any defects related to congenital abnormalities of the lymphatic system. One hypothesis for the absence of a phenotype in LYVE‐1 null mice is that other hyaluronan receptors, such as CD44, may compensate for LYVE‐1. To test this hypothesis, we created LYVE‐1/CD44 double knockout mice with appropriate littermate controls. Lymphatic vessel structure and function, as determined by histological methods and intravital microscopy, show that LYVE‐1−/−, CD44−/− and LYVE‐1−/−/CD44−/− mice are indistinguishable from wild‐type mice under normal conditions. Furthermore, resolution of carrageenan‐induced paw edema is comparable in all genotypes. However, LYVE‐1−/−/CD44−/− mice exhibit increased edema formation in a carrageenan‐induced paw inflammation model compared to wild‐type mice, but not to LYVE−/− or CD44−/− mice. These data suggest that LYVE‐1 and CD44 are not required for the formation or function of lymphatics, but do not rule out a role for LYVE‐1 in inflammation. J. Cell. Physiol. 219: 430–437, 2009. © 2009 Wiley‐Liss, Inc.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>Pays-Bas</li>
<li>États-Unis</li>
</country>
<region>
<li>Massachusetts</li>
<li>Utrecht (province)</li>
</region>
<settlement>
<li>Utrecht</li>
</settlement>
</list>
<tree>
<country name="États-Unis">
<region name="Massachusetts">
<name sortKey="Luong, Mai X" sort="Luong, Mai X" uniqKey="Luong M" first="Mai X." last="Luong">Mai X. Luong</name>
</region>
<name sortKey="Fukumura, Dai" sort="Fukumura, Dai" uniqKey="Fukumura D" first="Dai" last="Fukumura">Dai Fukumura</name>
<name sortKey="Hagendoorn, Jeroen" sort="Hagendoorn, Jeroen" uniqKey="Hagendoorn J" first="Jeroen" last="Hagendoorn">Jeroen Hagendoorn</name>
<name sortKey="Jain, Rakesh K" sort="Jain, Rakesh K" uniqKey="Jain R" first="Rakesh K." last="Jain">Rakesh K. Jain</name>
<name sortKey="Kucherlapati, Raju" sort="Kucherlapati, Raju" uniqKey="Kucherlapati R" first="Raju" last="Kucherlapati">Raju Kucherlapati</name>
<name sortKey="Lin, Qingcong" sort="Lin, Qingcong" uniqKey="Lin Q" first="Qingcong" last="Lin">Qingcong Lin</name>
<name sortKey="Moore, Kathryn J" sort="Moore, Kathryn J" uniqKey="Moore K" first="Kathryn J." last="Moore">Kathryn J. Moore</name>
<name sortKey="Padera, Timothy P" sort="Padera, Timothy P" uniqKey="Padera T" first="Timothy P." last="Padera">Timothy P. Padera</name>
<name sortKey="Seed, Brian" sort="Seed, Brian" uniqKey="Seed B" first="Brian" last="Seed">Brian Seed</name>
<name sortKey="Tam, Joshua" sort="Tam, Joshua" uniqKey="Tam J" first="Joshua" last="Tam">Joshua Tam</name>
<name sortKey="Tam, Joshua" sort="Tam, Joshua" uniqKey="Tam J" first="Joshua" last="Tam">Joshua Tam</name>
</country>
<country name="Pays-Bas">
<region name="Utrecht (province)">
<name sortKey="Hagendoorn, Jeroen" sort="Hagendoorn, Jeroen" uniqKey="Hagendoorn J" first="Jeroen" last="Hagendoorn">Jeroen Hagendoorn</name>
</region>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 006627 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 006627 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    LymphedemaV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     ISTEX:43406FCD0C22975E24F4CEC8596CA244EA8D546F
   |texte=   Lack of lymphatic vessel phenotype in LYVE‐1/CD44 double knockout mice
}}

Wicri

This area was generated with Dilib version V0.6.31.
Data generation: Sat Nov 4 17:40:35 2017. Site generation: Tue Feb 13 16:42:16 2024